Levaquin Lawsuit Consolidation Sought in New Jersey State Court

Lawyers representing plaintiffs who have filed a Levaquin lawsuit in state court in New Jersey have requested that all cases be centralized with Superior Court Judge Carol Higbee in Atlantic County.

The New Jersey Supreme Court has been asked to provide mass tort treatment to all lawsuits over Levaquin filed against Ortho-McNeil-Janssen Pharmaceuticals, involving allegations that side effects of the antibiotic caused users to suffer tendon ruptures and other permanent damage to their tendons.

Levaquin (levofloxacin) is an antibiotic that was first approved by the FDA in December 1996 to prevent infection by stopping reproduction of bacteria. It is available as an oral tablet, oral solution and as an injection.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

Side effects of Levaquin have been shown to increase the risk of tendonitis and tendon ruptures, particularly involving the achilles tendon.

In July 2008, the FDA required that a “black box” warning be placed on Levaquin and similar antibiotics, which is the strongest warning that can be placed on a prescription medication, warning about the risk of tendon ruptures and other tendon problems.

According to the New Jersey Law Journal, the Acting Administrative Director of the Courts in New Jersey has notified the Bar about the application to accord mass-tort treatment to the Levaquin lawsuits and solicited comments about the request on or before June 5, 2009.

All of the individual Levaquin lawsuit complaints involve similar allegations that the manufacturers failed to adequately research their product or warn about the potential tendon side effects. Since there will likely be thousands of similar lawsuits involving Levaquin filed throughout New Jersey, plaintiffs lawyers argue that the cases should be centralized for handling.

An MDL, or multidistrict litigaiton, has already been established for all Levaquin lawsuits filed in federal district courts throughout the country, consolidating the suits for pretrial litigation before U.S. District Judge John R. Tunheim in the District of Minnesota.

The federal cases were consolidated and centralized in June 2008, and a pretrial order issued earlier this year identified 15 cases that are going through case-specific discovery. The first bellwether Levaquin trial, which is designed to be representative of issues that will come up throughout other cases in the litigation, is currently scheduled to begin in August 2010.

Image Credit: |


  • CathySeptember 17, 2014 at 5:00 pm

    I have permanent damage in both ankles due to levaquin. I have received surgeries three times, but have minimally helped. I will eventually n need more surgeries.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Management of Ozempic Lawsuit Pretrial Proceedings To Be Reassigned Following Death of MDL Judge
Management of Ozempic Lawsuit Pretrial Proceedings To Be Reassigned Following Death of MDL Judge (Posted 2 days ago)

The judge overseeing Ozempic lawsuits consolidated in federal court has died, requiring a new judge to be assigned to oversee coordinated pretrial proceedings over claims the diabetes drug and similar medications caused stomach paralysis and other intestinal complications.